timber7 - your comments are spot on. People need to realise the gig is up, take a reality check and move on. The P3 result was a serious disaster and along with it the HA drug platform is in the skip. Reddy's have no intent on pushing fonda any further (they have bigger generics to focus on that are going to bring greater $$ in the door). Fonda is a drop in the ocean to them. The anti-coagulant market has moved on from injectables. If VAST was as good as it has been proclaimed to be it would of been snapped up by big pharma a long time ago. My mail is that the offices will be cleaned out by June 30.
- Forums
- ASX - By Stock
- ACL should try to replace Russian 3rd trial result with new other country's trial result
TSN
the sustainable nutrition group ltd
Add to My Watchlist
0.00%
!
1.0¢

timber7 - your comments are spot on. People need to realise the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online